Request Deal Involvement
Leaps by Bayer, Matrix-backed AyurMaya and Amgen Ventures led a $200m Series B funding round in ReCode Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Precision AQ
pr advisors
The Grace Communication Group
legal advisors
Wilson Sonsini Goodrich & Rosati
or
Principals
bidder
MPM CAPITAL
bidder
PFIZER VENTURES
target
RECODE THERAPEUTICS
bidder
MATRIX CAPITAL MANAGEMENT
bidder
SUPERSTRING CAPITAL
bidder
AMGEN VENTURES
bidder
OSAGE UNIVERSITY PARTNERS
bidder
ORBIMED ADVISORS LLC
bidder
LEAPS BY BAYER
bidder
NS INVESTMENT
bidder
AYURMAYA CAPITAL
bidder
ECOR1 CAPITAL
bidder
SANOFI VENTURES
bidder
VIDA VENTURES
bidder
COLT VENTURES
bidder
HUNT TECHNOLOGY VENTURES
bidder
TEKLA CAPITAL MANAGEMENT LLC
bidder
BLACKSTONE GROUP INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite